No description available.

L’infertilité concerne 8 à 12% des couples en âge de procréer. Face à ce problème, des prises en charge médicales peuvent être proposées comme la fécondation in vitro (FIV) et l’injection intracytoplasmique de spermatozoïde (ICSI). Toutefois, le taux d’échec de ces techniques reste relativement élevé. Dans la première partie, l’impact des facteurs maternels et paternels sur les résultats de 194 cycles de FIV et 586 cycles d’ICSI a été étudié. L’âge maternel, le nombre d’ovocytes ponctionnés et matures influencent principalement les résultats. Ni l’âge paternel ni les paramètres spermatiques (numération et mobilité) ne s’associent significativement à l’échec des techniques d’assistance médicale à la procréation (AMP). Seule la morphologie du spermatozoïde injecté a une influence sur la fécondation en ICSI. En deuxième partie, l’apoptose, la fragmentation de l’ADN et le contenu chromosomique avant et après tri cellulaire à l’aide des microbilles magnétiques ont été étudiés chez des hommes avec un taux de fragmentation de l’ADN spermatique anormal et chez des hommes porteurs d’une anomalie chromosomique constitutionnelle. Une diminution significative des spermatozoïdes apoptotiques avec un ADN fragmenté et chromosomiquement déséquilibrés a été observée. Le tri cellulaire aboutissant à une sélection de spermatozoïdes de meilleure qualité pourrait s’avérer une méthode de référence pour l’AMP. Dans une troisième partie, un protocole fiable a été élaboré pour étudier le transcriptome des spermatozoïdes. La mise au point de ces technologies permettra de mieux comprendre les causes d’échec des techniques d’AMP et ainsi améliorer leur taux de réussite. / Infertility concerns 8-12% of couples of reproductive age. Various medical treatments such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) are available to address this problem. However the rate of failure of these procedures remains relatively high.In the first part of this work the impact of maternal and paternal factors on the results of 194 IVF cycles and 586 ICSI cycles was studied. Results are mainly affected by maternal age, the number of oocytes retrieved and the number of mature oocytes collected. Neither paternal age nor spermatic parameters (number and mobility) are significantly associated with the failure of Assisted Reproductive Technologies (ART). Only the morphology of the sperm injected during ICSI influences fertilization rate.In the second part of this work apoptosis, DNA fragmentation and the chromosomal content before and after cell sorting with magnetic micro beads were studied in men with an abnormal level of sperm DNA fragmentation and in men with a constitutional chromosome abnormality. A significant decrease of apoptic spermatozoa with fragmented DNA and chromosome imbalance was observed. Thus cell sorting leading to the selection of better quality spermatozoa could become a reference method for ART.In a third part of the work a reliable protocol for the study of spermatic transcriptomes is designed.The development of these technologies will lead to a better understanding of the underlying causes ofART failure and thus increase the success rate.

Confronted with the global demographic changes and the increasing pressure on modern healthcare system, there has been a surge of developing new technology platforms in the past decades. Droplet microfluidics is a prominent example of such technology platforms, which offers an efficient format for massively parallelized screening of a large number of samples and holds great promise to boost the throughput and reduce the costs of modern biomedical activities. Despite recent achievements, the realization of a compact and generic screening system which is suited for resource-limited settings and point-of-care applications remains elusive. To address the above challenges, the dissertation focuses on the development of a compact multifunctional droplet micro-magnetofluidic system by exploring the advantages of magnetic in-flow detection principles. The methodologies behind a novel technique for biomedical applications, namely, magnetic in-flow cytometry have been put forth, which encompass magnetic indexing schemes, quantitative multiparametric analytics and magnetically-activated sorting. A magnetic indexing scheme is introduced and intrinsic to the magnetofluidic system. Two parameters characteristic of the magnetic signal when detecting magnetically functionalized objects, i.e. signal amplitude and peak width, providing information which is necessary to perform quantitative analysis in the spirit of optical cytometry has been proposed and realized. Magnetically-activated sorting is demonstrated to actively select individual droplets or to purify a population of droplets of interest. Together with the magnetic indexing scheme and multiparametric analytic technique, this functionality synergistically enables controlled synthesis, quality administration and screening of encoded magnetic microcarriers, which is crucial for the practical realization of magnetic suspension arrays technologies. Furthermore, to satisfy the needs of cost-efficient fabrication and high-volume delivery, an approach to fabricate magnetofluidic devices on flexible foils is demonstrated. The resultant device retains high performance of its rigid counterpart and exhibits excellent mechanical properties, which promises long-term stability in practical applications.

Confronted with the global demographic changes and the increasing pressure on modern healthcare system, there has been a surge of developing new technology platforms in the past decades. Droplet microfluidics is a prominent example of such technology platforms, which offers an efficient format for massively parallelized screening of a large number of samples and holds great promise to boost the throughput and reduce the costs of modern biomedical activities. Despite recent achievements, the realization of a compact and generic screening system which is suited for resource-limited settings and point-of-care applications remains elusive. To address the above challenges, the dissertation focuses on the development of a compact multifunctional droplet micro-magnetofluidic system by exploring the advantages of magnetic in-flow detection principles. The methodologies behind a novel technique for biomedical applications, namely, magnetic in-flow cytometry have been put forth, which encompass magnetic indexing schemes, quantitative multiparametric analytics and magnetically-activated sorting. A magnetic indexing scheme is introduced and intrinsic to the magnetofluidic system. Two parameters characteristic of the magnetic signal when detecting magnetically functionalized objects, i.e. signal amplitude and peak width, providing information which is necessary to perform quantitative analysis in the spirit of optical cytometry has been proposed and realized. Magnetically-activated sorting is demonstrated to actively select individual droplets or to purify a population of droplets of interest. Together with the magnetic indexing scheme and multiparametric analytic technique, this functionality synergistically enables controlled synthesis, quality administration and screening of encoded magnetic microcarriers, which is crucial for the practical realization of magnetic suspension arrays technologies. Furthermore, to satisfy the needs of cost-efficient fabrication and high-volume delivery, an approach to fabricate magnetofluidic devices on flexible foils is demonstrated. The resultant device retains high performance of its rigid counterpart and exhibits excellent mechanical properties, which promises long-term stability in practical applications.